1. Home
  2. NKTX vs QH Comparison

NKTX vs QH Comparison

Compare NKTX & QH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • QH
  • Stock Information
  • Founded
  • NKTX 2015
  • QH 2012
  • Country
  • NKTX United States
  • QH China
  • Employees
  • NKTX N/A
  • QH N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • QH Business Services
  • Sector
  • NKTX Health Care
  • QH Consumer Discretionary
  • Exchange
  • NKTX Nasdaq
  • QH Nasdaq
  • Market Cap
  • NKTX 123.5M
  • QH 115.7M
  • IPO Year
  • NKTX 2020
  • QH 2020
  • Fundamental
  • Price
  • NKTX $2.37
  • QH $0.06
  • Analyst Decision
  • NKTX Strong Buy
  • QH
  • Analyst Count
  • NKTX 5
  • QH 0
  • Target Price
  • NKTX $13.50
  • QH N/A
  • AVG Volume (30 Days)
  • NKTX 556.1K
  • QH 22.9M
  • Earning Date
  • NKTX 08-12-2025
  • QH 09-02-2025
  • Dividend Yield
  • NKTX N/A
  • QH N/A
  • EPS Growth
  • NKTX N/A
  • QH N/A
  • EPS
  • NKTX N/A
  • QH 0.01
  • Revenue
  • NKTX N/A
  • QH $417,431,053.00
  • Revenue This Year
  • NKTX N/A
  • QH N/A
  • Revenue Next Year
  • NKTX N/A
  • QH N/A
  • P/E Ratio
  • NKTX N/A
  • QH $6.75
  • Revenue Growth
  • NKTX N/A
  • QH N/A
  • 52 Week Low
  • NKTX $1.31
  • QH $0.06
  • 52 Week High
  • NKTX $6.63
  • QH $2.27
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 64.66
  • QH 20.73
  • Support Level
  • NKTX $2.23
  • QH $0.06
  • Resistance Level
  • NKTX $2.50
  • QH $0.11
  • Average True Range (ATR)
  • NKTX 0.13
  • QH 0.01
  • MACD
  • NKTX 0.02
  • QH 0.03
  • Stochastic Oscillator
  • NKTX 76.85
  • QH 6.99

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About QH Quhuo Limited American Depository Shares

Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services.

Share on Social Networks: